Avivagen Inc.

04/20/2023

Avivagen Inc., a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance, today announced the results of its annual general meeting of shareholders held on April 19, 2023.

Ottawa, ON /Business Wire/ April 19, 2023 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports...

02/21/2023

📢Avivagen Reports Fiscal Year 2022 Financial Results and Strategic Initiatives to Accelerate Growth
👉New approvals for sales in multiple countries
👉Raised more than $8.5 million in equity and debt financing
👉Revenues of approximately $1 million
👉Succession plan implemented to support next phase of accelerated growth

Read the full release here: https://avivagen.com/fiscal-2022-results/

01/19/2023

📙We're proud to announce publication of a new paper in the journal Animals.

The Publication showcases the cumulative understanding to-date of Avivagen’s product from both a scientific and real world application perspective.

🔍More details:

https://avivagen.com/scientific-commercial-evidence/

$VIV.V

Publication showcases the cumulative understanding to-date of Avivagen’s product from both a scientific and real world application perspective Product’s value and safety has been shown through use in many settings, under differing conditions and in millions of animals   Ottawa, ON /Business Wir...

11/01/2022

📈Avivagen Inc. Announces Closing of Second Tranche of a Private Placement of Shares

The Company issued 875,000 Common Shares, for aggregate gross proceeds of $175,000 in the Second Tranche. In the aggregate of all two tranches of the Offering, the Company issued 3,025,000 Common Shares for gross proceeds of $605,000.

Ottawa, ON / Business Wire/ October 31, 2022 – Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, ther...

06/09/2022

Avivagen is pleased to announce that it has completed a series of important safety evaluations of fully oxidized beta-carotene (OxBC), the proprietary and critical active ingredient in the company’s highly-regarded OxC-betaTM product line. Results of the Avivagen-initiated toxicology study, conducted following standardized and internationally recognized protocols, provided further evidence of the safety and effectiveness of OxBC and the OxC-betaTM product line for use in human and animal applications.

Read the full press release:

https://avivagen.com/safety-and-toxicology-results/


$VIV.V -beta

Ottawa, ON /Business Wire/ June 9, 2022 /- Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, ther...

06/08/2022

OxBC, the richest and purest source of β-carotene-oxygen copolymer compounds, is economically produced synthetically by air-oxidation by a global β-carotene manufacturer.

Learn more www.avivagen.com
$VIV.V "

05/30/2022

📢 Avivagen Signs New Distribution Partner in Vietnam to Support Southeast Asian Growth

👉 Read the full press release:

Ottawa, ON /Business Wire/ May 30, 2022 /- Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, ther...

05/12/2022

📢 Avivagen Announces Approval in China, the World’s Largest Commercial Feed Production Market

China was ranked as the number one feed-producing country in the world in the 2022 Alltech Agri-Food Outlook, producing 261.4mmt in 2021.

https://avivagen.com/approval-in-china/

$VIV.V

Ottawa, ON /Business Wire/ May 12, 2022 /– Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, th...

03/28/2022

Avivagen is pleased to announce that it has closed its previously announced private placement financing of secured debentures for gross proceeds of $5.678 million.
Learn More: https://avivagen.com/private-placement-of-debentures-shares/

$VIV.V

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Ottawa, ON – March 28, 2022 — Avivagen Inc. (TSXV:VIV) (“Avivagen” or the “Company”), a life sciences corporation f...

03/22/2022

Avivagen is pleased to announce that it will be a presenter at the Annual Alpha North Capital Event organized by CEM Events (CEM.ca) which takes place in The Bahamas between March 25 - 27, 2022. The invite only conference introduces growth-stage companies to active top-level capital finance individuals through a day of scheduled one-on-one meetings and networking activities. Avivagen will be represented by Mr. Kym Anthony, CEO and Dr. Jamie Nickerson, President.

CEM $VIV.V

03/15/2022

Our team ❤️s their pets too!

Animals are not only good life companions, but they are also good for your ! Studies show that pet owners have:

✔️ Lower cholesterol
✔️ Lower blood pressure
✔️ Lower allergies
✔️ Lower risk of heart disease

So return the favour and look after your pet's health! 💙🐾

-

Les animaux sont non seulement de bons compagnons de vie, mais ils sont également bons pour votre ! Des études démontrent que les propriétaires d'animaux de compagnie ont:

✔️ Un taux de cholestérol plus bas
✔️ Une tension artérielle plus basse
✔️ Des allergies plus faibles
✔️ Un risque de maladies cardiaques moins élevé

Alors, retournez-leur la pareille et prenez soin de la santé de votre animal! 💙🐾

03/10/2022

Three things to know this Thursday:
🥕Transformative Supply Agreement
🥕 Trials underway throughout the year
🥕 Two markets, five regions: regulatory approval sought for companion animal & human health

$VIV.V